Assessment of the Safety and Performance of Knee Ligament Supports in the Context of a Return to Sport After Sprain
NCT ID: NCT04592471
Last Updated: 2022-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2021-03-05
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The difference between these devices is based on the strength of compression and the knee maintain.
The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon kneeMID500-STRONG700 products to demonstrate safety and performance of these devices in a real-world setting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Distribution of Knee Isokinetic Angle-specific Moments and Ratios
NCT05041400
Proprioceptive Isokinetic Repositioning, Functional Testing, and a Self-reported Questionnaire Before and After Anterior Cruciate Ligament Reconstruction
NCT04058574
Association Between 4-Month Isokinetic Testing Measures and Second Knee Injuries After Primary Anterior Cruciate Ligament Reconstruction
NCT05897970
Meniscal Lesions in Return to Sport After Anterior Cruciate Ligament Reconstruction
NCT04129827
Laval University Rouge et or Post ACL Surgery Program Effectiveness
NCT04137003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Orthosis Group 1
Use of kneeMID500 device
kneeMID500-STRONG700
At least 30 patients (15 patients in the orthosis group and 15 patients in the control group) per device type (2 device types: Knee MID 500 and Knee STRONG 700) totalling 60 patients will be included. Patients included in the orthosis group will use the device during sports sessions while patients included in the control group will not use a knee support device.
Control Group 1
Control Group of the kneeMID500 Orthosis Group - No use of the device
No interventions assigned to this group
Orthosis Group 2
Use of kneeSTRONG700 device
kneeMID500-STRONG700
At least 30 patients (15 patients in the orthosis group and 15 patients in the control group) per device type (2 device types: Knee MID 500 and Knee STRONG 700) totalling 60 patients will be included. Patients included in the orthosis group will use the device during sports sessions while patients included in the control group will not use a knee support device.
Control Group 2
Control Group of the kneeSTRONG700 Orthosis Group - No use of the device
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
kneeMID500-STRONG700
At least 30 patients (15 patients in the orthosis group and 15 patients in the control group) per device type (2 device types: Knee MID 500 and Knee STRONG 700) totalling 60 patients will be included. Patients included in the orthosis group will use the device during sports sessions while patients included in the control group will not use a knee support device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has a recent mild (grade I) OR moderate (grade II) knee sprain OR an ACL surgery
* The current condition of his/her knee allows the subject to resume usual physical activity
* Subject has been informed and is willing to sign an informed consent form
* Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (18 weeks)
* Subject is affiliated to the French social security regime
* Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent
* Subject has worn a support (knee brace or articulated orthosis) since his/her recent injury
* Subject has resumed regular physical activity since his/her recent injury
* Subject has any medical condition that could impact the study at investigator's discretion
* Subject has a known hypersensitivity or allergy to the components of the device (polyamide, elastane, elastodiene)
* Adult subject to a legal protection measure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
EFOR, France
INDUSTRY
Decathlon SE
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valérie WIECZOREK
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de rééducation et de balnéothérapie Kinés Faches
Faches-Thumesnil, , France
Centre Hospitalier Universitaire de Lille
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Loïc RAUSENBERGER
Role: primary
Valérie WIECZOREK
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
kneeMID500-STRONG700
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.